nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—CHRM3—ureter—urinary bladder cancer	0.253	0.402	CbGeAlD
Propantheline—CHRM3—muscle of abdomen—urinary bladder cancer	0.182	0.29	CbGeAlD
Propantheline—CHRM2—prostate gland—urinary bladder cancer	0.0362	0.0576	CbGeAlD
Propantheline—CHRM1—prostate gland—urinary bladder cancer	0.033	0.0525	CbGeAlD
Propantheline—CHRM3—prostate gland—urinary bladder cancer	0.0295	0.0469	CbGeAlD
Propantheline—CHRM3—smooth muscle tissue—urinary bladder cancer	0.0209	0.0332	CbGeAlD
Propantheline—CHRM3—renal system—urinary bladder cancer	0.0201	0.032	CbGeAlD
Propantheline—CHRM3—urethra—urinary bladder cancer	0.0198	0.0314	CbGeAlD
Propantheline—CHRM1—female reproductive system—urinary bladder cancer	0.018	0.0286	CbGeAlD
Propantheline—CHRM3—female reproductive system—urinary bladder cancer	0.0161	0.0256	CbGeAlD
Propantheline—Dermatitis atopic—Gemcitabine—urinary bladder cancer	0.00992	0.0267	CcSEcCtD
Propantheline—Drowsiness—Mitomycin—urinary bladder cancer	0.00971	0.0262	CcSEcCtD
Propantheline—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00741	0.02	CcSEcCtD
Propantheline—Vision blurred—Mitomycin—urinary bladder cancer	0.00715	0.0193	CcSEcCtD
Propantheline—Asthenia—Valrubicin—urinary bladder cancer	0.00645	0.0174	CcSEcCtD
Propantheline—Confusional state—Mitomycin—urinary bladder cancer	0.00624	0.0168	CcSEcCtD
Propantheline—Dizziness—Valrubicin—urinary bladder cancer	0.00594	0.016	CcSEcCtD
Propantheline—Vomiting—Valrubicin—urinary bladder cancer	0.00572	0.0154	CcSEcCtD
Propantheline—Rash—Valrubicin—urinary bladder cancer	0.00567	0.0153	CcSEcCtD
Propantheline—Dermatitis—Valrubicin—urinary bladder cancer	0.00566	0.0153	CcSEcCtD
Propantheline—Headache—Valrubicin—urinary bladder cancer	0.00563	0.0152	CcSEcCtD
Propantheline—Somnolence—Mitomycin—urinary bladder cancer	0.00551	0.0148	CcSEcCtD
Propantheline—Nausea—Valrubicin—urinary bladder cancer	0.00534	0.0144	CcSEcCtD
Propantheline—Feeling abnormal—Mitomycin—urinary bladder cancer	0.0051	0.0138	CcSEcCtD
Propantheline—Dermatitis atopic—Epirubicin—urinary bladder cancer	0.00475	0.0128	CcSEcCtD
Propantheline—Dysphagia—Fluorouracil—urinary bladder cancer	0.00453	0.0122	CcSEcCtD
Propantheline—Asthenia—Mitomycin—urinary bladder cancer	0.00444	0.012	CcSEcCtD
Propantheline—Dermatitis atopic—Doxorubicin—urinary bladder cancer	0.00439	0.0118	CcSEcCtD
Propantheline—Dizziness—Mitomycin—urinary bladder cancer	0.0041	0.011	CcSEcCtD
Propantheline—Vomiting—Mitomycin—urinary bladder cancer	0.00394	0.0106	CcSEcCtD
Propantheline—Dysphagia—Etoposide—urinary bladder cancer	0.00393	0.0106	CcSEcCtD
Propantheline—Rash—Mitomycin—urinary bladder cancer	0.0039	0.0105	CcSEcCtD
Propantheline—Dermatitis—Mitomycin—urinary bladder cancer	0.0039	0.0105	CcSEcCtD
Propantheline—Headache—Mitomycin—urinary bladder cancer	0.00388	0.0105	CcSEcCtD
Propantheline—Tension—Thiotepa—urinary bladder cancer	0.00374	0.0101	CcSEcCtD
Propantheline—Nervousness—Thiotepa—urinary bladder cancer	0.00371	0.00999	CcSEcCtD
Propantheline—Nausea—Mitomycin—urinary bladder cancer	0.00368	0.00992	CcSEcCtD
Propantheline—Vision blurred—Thiotepa—urinary bladder cancer	0.0036	0.0097	CcSEcCtD
Propantheline—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.00341	0.0092	CcSEcCtD
Propantheline—Flushing—Cisplatin—urinary bladder cancer	0.00319	0.0086	CcSEcCtD
Propantheline—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.00316	0.00851	CcSEcCtD
Propantheline—Confusional state—Thiotepa—urinary bladder cancer	0.00314	0.00847	CcSEcCtD
Propantheline—Tachycardia—Thiotepa—urinary bladder cancer	0.00304	0.00819	CcSEcCtD
Propantheline—Vision blurred—Fluorouracil—urinary bladder cancer	0.00297	0.00802	CcSEcCtD
Propantheline—Flushing—Etoposide—urinary bladder cancer	0.00292	0.00788	CcSEcCtD
Propantheline—Vision blurred—Cisplatin—urinary bladder cancer	0.00282	0.0076	CcSEcCtD
Propantheline—Somnolence—Thiotepa—urinary bladder cancer	0.00277	0.00746	CcSEcCtD
Propantheline—Constipation—Thiotepa—urinary bladder cancer	0.00266	0.00718	CcSEcCtD
Propantheline—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00262	0.00706	CcSEcCtD
Propantheline—Confusional state—Fluorouracil—urinary bladder cancer	0.0026	0.007	CcSEcCtD
Propantheline—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00258	0.00694	CcSEcCtD
Propantheline—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00257	0.00692	CcSEcCtD
Propantheline—Tachycardia—Fluorouracil—urinary bladder cancer	0.00251	0.00678	CcSEcCtD
Propantheline—Urticaria—Thiotepa—urinary bladder cancer	0.00247	0.00667	CcSEcCtD
Propantheline—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00244	0.00658	CcSEcCtD
Propantheline—Tachycardia—Cisplatin—urinary bladder cancer	0.00238	0.00642	CcSEcCtD
Propantheline—Insomnia—Gemcitabine—urinary bladder cancer	0.00237	0.00639	CcSEcCtD
Propantheline—Insomnia—Fluorouracil—urinary bladder cancer	0.00233	0.00628	CcSEcCtD
Propantheline—Somnolence—Gemcitabine—urinary bladder cancer	0.00233	0.00628	CcSEcCtD
Propantheline—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00229	0.00619	CcSEcCtD
Propantheline—Somnolence—Fluorouracil—urinary bladder cancer	0.00229	0.00617	CcSEcCtD
Propantheline—Confusional state—Etoposide—urinary bladder cancer	0.00226	0.00608	CcSEcCtD
Propantheline—Constipation—Gemcitabine—urinary bladder cancer	0.00224	0.00604	CcSEcCtD
Propantheline—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00224	0.00603	CcSEcCtD
Propantheline—Asthenia—Thiotepa—urinary bladder cancer	0.00223	0.00602	CcSEcCtD
Propantheline—Abdominal distension—Epirubicin—urinary bladder cancer	0.00222	0.00598	CcSEcCtD
Propantheline—Dysphagia—Epirubicin—urinary bladder cancer	0.00221	0.00594	CcSEcCtD
Propantheline—Tachycardia—Etoposide—urinary bladder cancer	0.00218	0.00589	CcSEcCtD
Propantheline—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00217	0.00585	CcSEcCtD
Propantheline—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00216	0.00582	CcSEcCtD
Propantheline—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00212	0.00572	CcSEcCtD
Propantheline—Drowsiness—Methotrexate—urinary bladder cancer	0.0021	0.00566	CcSEcCtD
Propantheline—Dizziness—Thiotepa—urinary bladder cancer	0.00206	0.00555	CcSEcCtD
Propantheline—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00205	0.00554	CcSEcCtD
Propantheline—Urticaria—Fluorouracil—urinary bladder cancer	0.00205	0.00552	CcSEcCtD
Propantheline—Dysphagia—Doxorubicin—urinary bladder cancer	0.00204	0.0055	CcSEcCtD
Propantheline—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00201	0.00542	CcSEcCtD
Propantheline—Somnolence—Etoposide—urinary bladder cancer	0.00199	0.00536	CcSEcCtD
Propantheline—Vomiting—Thiotepa—urinary bladder cancer	0.00198	0.00534	CcSEcCtD
Propantheline—Drowsiness—Epirubicin—urinary bladder cancer	0.00197	0.0053	CcSEcCtD
Propantheline—Rash—Thiotepa—urinary bladder cancer	0.00196	0.00529	CcSEcCtD
Propantheline—Dermatitis—Thiotepa—urinary bladder cancer	0.00196	0.00529	CcSEcCtD
Propantheline—Headache—Thiotepa—urinary bladder cancer	0.00195	0.00526	CcSEcCtD
Propantheline—Constipation—Etoposide—urinary bladder cancer	0.00191	0.00516	CcSEcCtD
Propantheline—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.0019	0.00512	CcSEcCtD
Propantheline—Asthenia—Gemcitabine—urinary bladder cancer	0.00188	0.00507	CcSEcCtD
Propantheline—Nausea—Thiotepa—urinary bladder cancer	0.00185	0.00499	CcSEcCtD
Propantheline—Feeling abnormal—Etoposide—urinary bladder cancer	0.00184	0.00497	CcSEcCtD
Propantheline—Drowsiness—Doxorubicin—urinary bladder cancer	0.00182	0.0049	CcSEcCtD
Propantheline—Hypersensitivity—Cisplatin—urinary bladder cancer	0.0018	0.00485	CcSEcCtD
Propantheline—Urticaria—Etoposide—urinary bladder cancer	0.00178	0.00479	CcSEcCtD
Propantheline—Asthenia—Cisplatin—urinary bladder cancer	0.00175	0.00472	CcSEcCtD
Propantheline—Dizziness—Fluorouracil—urinary bladder cancer	0.0017	0.00459	CcSEcCtD
Propantheline—Vomiting—Gemcitabine—urinary bladder cancer	0.00167	0.00449	CcSEcCtD
Propantheline—Rash—Gemcitabine—urinary bladder cancer	0.00165	0.00445	CcSEcCtD
Propantheline—Dermatitis—Gemcitabine—urinary bladder cancer	0.00165	0.00445	CcSEcCtD
Propantheline—Hypersensitivity—Etoposide—urinary bladder cancer	0.00165	0.00444	CcSEcCtD
Propantheline—Headache—Gemcitabine—urinary bladder cancer	0.00164	0.00442	CcSEcCtD
Propantheline—Flushing—Epirubicin—urinary bladder cancer	0.00164	0.00442	CcSEcCtD
Propantheline—Vomiting—Fluorouracil—urinary bladder cancer	0.00164	0.00442	CcSEcCtD
Propantheline—Rash—Fluorouracil—urinary bladder cancer	0.00162	0.00438	CcSEcCtD
Propantheline—Dermatitis—Fluorouracil—urinary bladder cancer	0.00162	0.00437	CcSEcCtD
Propantheline—Headache—Fluorouracil—urinary bladder cancer	0.00161	0.00435	CcSEcCtD
Propantheline—Asthenia—Etoposide—urinary bladder cancer	0.00161	0.00433	CcSEcCtD
Propantheline—Nausea—Gemcitabine—urinary bladder cancer	0.00156	0.0042	CcSEcCtD
Propantheline—Vomiting—Cisplatin—urinary bladder cancer	0.00155	0.00419	CcSEcCtD
Propantheline—Vision blurred—Methotrexate—urinary bladder cancer	0.00155	0.00417	CcSEcCtD
Propantheline—Rash—Cisplatin—urinary bladder cancer	0.00154	0.00415	CcSEcCtD
Propantheline—Dermatitis—Cisplatin—urinary bladder cancer	0.00154	0.00415	CcSEcCtD
Propantheline—Nausea—Fluorouracil—urinary bladder cancer	0.00153	0.00412	CcSEcCtD
Propantheline—Flushing—Doxorubicin—urinary bladder cancer	0.00152	0.00409	CcSEcCtD
Propantheline—Tension—Epirubicin—urinary bladder cancer	0.00151	0.00406	CcSEcCtD
Propantheline—Nervousness—Epirubicin—urinary bladder cancer	0.00149	0.00402	CcSEcCtD
Propantheline—Dizziness—Etoposide—urinary bladder cancer	0.00148	0.00399	CcSEcCtD
Propantheline—Nausea—Cisplatin—urinary bladder cancer	0.00145	0.00391	CcSEcCtD
Propantheline—Vision blurred—Epirubicin—urinary bladder cancer	0.00145	0.0039	CcSEcCtD
Propantheline—Vomiting—Etoposide—urinary bladder cancer	0.00142	0.00383	CcSEcCtD
Propantheline—Rash—Etoposide—urinary bladder cancer	0.00141	0.0038	CcSEcCtD
Propantheline—Dermatitis—Etoposide—urinary bladder cancer	0.00141	0.0038	CcSEcCtD
Propantheline—Headache—Etoposide—urinary bladder cancer	0.0014	0.00378	CcSEcCtD
Propantheline—Tension—Doxorubicin—urinary bladder cancer	0.0014	0.00376	CcSEcCtD
Propantheline—Nervousness—Doxorubicin—urinary bladder cancer	0.00138	0.00372	CcSEcCtD
Propantheline—Palpitations—Epirubicin—urinary bladder cancer	0.00136	0.00366	CcSEcCtD
Propantheline—Confusional state—Methotrexate—urinary bladder cancer	0.00135	0.00364	CcSEcCtD
Propantheline—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00134	0.00361	CcSEcCtD
Propantheline—Vision blurred—Doxorubicin—urinary bladder cancer	0.00134	0.00361	CcSEcCtD
Propantheline—Nausea—Etoposide—urinary bladder cancer	0.00133	0.00358	CcSEcCtD
Propantheline—Dry mouth—Epirubicin—urinary bladder cancer	0.00128	0.00345	CcSEcCtD
Propantheline—Confusional state—Epirubicin—urinary bladder cancer	0.00126	0.00341	CcSEcCtD
Propantheline—Palpitations—Doxorubicin—urinary bladder cancer	0.00126	0.00339	CcSEcCtD
Propantheline—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00125	0.00338	CcSEcCtD
Propantheline—Tachycardia—Epirubicin—urinary bladder cancer	0.00122	0.0033	CcSEcCtD
Propantheline—Insomnia—Methotrexate—urinary bladder cancer	0.00121	0.00327	CcSEcCtD
Propantheline—Somnolence—Methotrexate—urinary bladder cancer	0.00119	0.00321	CcSEcCtD
Propantheline—Dry mouth—Doxorubicin—urinary bladder cancer	0.00118	0.00319	CcSEcCtD
Propantheline—Confusional state—Doxorubicin—urinary bladder cancer	0.00117	0.00315	CcSEcCtD
Propantheline—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00116	0.00313	CcSEcCtD
Propantheline—Insomnia—Epirubicin—urinary bladder cancer	0.00113	0.00306	CcSEcCtD
Propantheline—Tachycardia—Doxorubicin—urinary bladder cancer	0.00113	0.00305	CcSEcCtD
Propantheline—Somnolence—Epirubicin—urinary bladder cancer	0.00111	0.00301	CcSEcCtD
Propantheline—Feeling abnormal—Methotrexate—urinary bladder cancer	0.0011	0.00298	CcSEcCtD
Propantheline—Constipation—Epirubicin—urinary bladder cancer	0.00107	0.00289	CcSEcCtD
Propantheline—Urticaria—Methotrexate—urinary bladder cancer	0.00106	0.00287	CcSEcCtD
Propantheline—Insomnia—Doxorubicin—urinary bladder cancer	0.00105	0.00283	CcSEcCtD
Propantheline—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00103	0.00279	CcSEcCtD
Propantheline—Somnolence—Doxorubicin—urinary bladder cancer	0.00103	0.00278	CcSEcCtD
Propantheline—Urticaria—Epirubicin—urinary bladder cancer	0.000996	0.00269	CcSEcCtD
Propantheline—Constipation—Doxorubicin—urinary bladder cancer	0.000992	0.00267	CcSEcCtD
Propantheline—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000987	0.00266	CcSEcCtD
Propantheline—Asthenia—Methotrexate—urinary bladder cancer	0.000961	0.00259	CcSEcCtD
Propantheline—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000956	0.00258	CcSEcCtD
Propantheline—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000924	0.00249	CcSEcCtD
Propantheline—Urticaria—Doxorubicin—urinary bladder cancer	0.000922	0.00248	CcSEcCtD
Propantheline—Asthenia—Epirubicin—urinary bladder cancer	0.0009	0.00243	CcSEcCtD
Propantheline—Dizziness—Methotrexate—urinary bladder cancer	0.000886	0.00239	CcSEcCtD
Propantheline—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000855	0.0023	CcSEcCtD
Propantheline—Vomiting—Methotrexate—urinary bladder cancer	0.000852	0.0023	CcSEcCtD
Propantheline—Rash—Methotrexate—urinary bladder cancer	0.000845	0.00228	CcSEcCtD
Propantheline—Dermatitis—Methotrexate—urinary bladder cancer	0.000844	0.00228	CcSEcCtD
Propantheline—Headache—Methotrexate—urinary bladder cancer	0.00084	0.00226	CcSEcCtD
Propantheline—Asthenia—Doxorubicin—urinary bladder cancer	0.000833	0.00224	CcSEcCtD
Propantheline—Dizziness—Epirubicin—urinary bladder cancer	0.000829	0.00224	CcSEcCtD
Propantheline—Vomiting—Epirubicin—urinary bladder cancer	0.000797	0.00215	CcSEcCtD
Propantheline—Nausea—Methotrexate—urinary bladder cancer	0.000796	0.00215	CcSEcCtD
Propantheline—Rash—Epirubicin—urinary bladder cancer	0.000791	0.00213	CcSEcCtD
Propantheline—Dermatitis—Epirubicin—urinary bladder cancer	0.00079	0.00213	CcSEcCtD
Propantheline—Headache—Epirubicin—urinary bladder cancer	0.000786	0.00212	CcSEcCtD
Propantheline—Dizziness—Doxorubicin—urinary bladder cancer	0.000767	0.00207	CcSEcCtD
Propantheline—Nausea—Epirubicin—urinary bladder cancer	0.000745	0.00201	CcSEcCtD
Propantheline—Vomiting—Doxorubicin—urinary bladder cancer	0.000738	0.00199	CcSEcCtD
Propantheline—Rash—Doxorubicin—urinary bladder cancer	0.000732	0.00197	CcSEcCtD
Propantheline—Dermatitis—Doxorubicin—urinary bladder cancer	0.000731	0.00197	CcSEcCtD
Propantheline—Headache—Doxorubicin—urinary bladder cancer	0.000727	0.00196	CcSEcCtD
Propantheline—Nausea—Doxorubicin—urinary bladder cancer	0.000689	0.00186	CcSEcCtD
